Skip to main content

Header Nav

About
Products
Pipeline
Impact
Investors
Careers
Contact us

Header Nav

About
Products
Pipeline
Impact
Investors
Careers
Contact us

Investors Menu

Investor Relations

Investor Center Home
Press Releases
Corporate Governance
Stock Information
SEC Filings
Events & Presentations
Annual Reports
Investor FAQs
Contact IR

Press Releases

Press Releases

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014

Eagle Pharmaceuticals Provides 2022 Business Update and Announces Launch of Vasopressin

1/5/22

Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

1/3/22

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Change % Volume Data as of 12/22/2024 5:48 AM EST Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

Investor Center Home
Press Releases
Corporate Governance
Stock Information
SEC Filings
Events & Presentations
Annual Reports
Investor FAQs
Contact IR

Search

Sidebar Links

Email Alerts
RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links

privacy policy
terms of use
sitemap
contact us

© 2024 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677